VEGFA and age-related macular degeneration: We defined non-persistence (loss to follow-up—LTFU) in AMD patients treated with anti-vascular endothelial growth factor (anti-VEGF) therapy as missing any treatment or monitoring visits, or not scheduling follow-ups for six months.